Abdelbary Elhissi is a Senior Lecturer in Pharmaceutics and the Head of Drug, Gene and Protein Delivery Research Group at the Institute of Nanotechnology and Bioengineering, School of Pharmacy and Biomedical Sciences, University of Central Lancashire.
Abdelbary graduated from the Faculty of Pharmacy, October 6th University, Egypt in 1999 with Hons, distinction and had the highest grade in his year. He joined the School of Pharmacy, University of London as a PhD student and completed his PhD in Pharmaceutics in 2005 under the supervision of Professor Kevin Taylor and also worked as a Postdoctoral Research Fellow in Clinical Pharmaceutics. In November 2006 he joined Lipoxen as a Senior Scientist. Currently, Abdelbary is leading research in Drug Delivery and has established one of the largest groups in this field within the Institute of Nanotechnology and Bioengineering, University of Central Lancashire. Abdelbary’s group is currently working on development of lipid and polymer-based formulations for respiratory drug delivery and cancer treatment in collaboration with UCL-School of Pharmacy, University of London and West China School of Pharmacy, Sichuan University.
I am the Head of Institute of Nanotechnology and Bioengineeirng at UCLAN. My research interest is in nanotechnology for applications that will improve the world in which we live. I am interested developing and maximising the potential of young people and turn them into leaders in research and in their communities. They will use thier talents and abilities to make the world a better and happer place for everyone on all continents.